#JPM25 live blog: How will Trump 2.0 impact the biopharma industry? Scott Gottlieb, Bob Nelsen share perspectives
It’s day 1 at the JP Morgan Healthcare Conference, and as the day progressed, new major themes emerged: What does the morning’s dealmaking tell us …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
